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P U B L I S H E D B Y E L S E V I E R I N C .LettersPrevalence and
Clinical Signiﬁcance of
Life-Threatening
Arrhythmias in
Takotsubo CardiomyopathyAlthough prognosis of Takotsubo cardiomyopathy
(TTC) is generally thought to be favorable, the initial
presentation can be accompanied by various compli-
cations, including life-threatening arrhythmias. Pre-
viously, the prevalence of ventricular tachycardia
(VT), ventricular ﬁbrillation (VF), or complete atrio-
ventricular (AV) block was reported to be approxi-
mately 8%, mostly in the setting of QT prolongation
(1,2). However, data regarding the exact prevalence,
optimal management, and prognostic relevance of
arrhythmias in TTC patients are lacking.
This single-center study consisted of 203 consec-
utive patients with suspected TTC presenting to
our institution. Of these, 25 patients were excluded
because of cardiovascular magnetic resonance (CMR)
evidence of acute myocardial infarction with spon-
taneous lysis of thrombus and myocarditis. TTC
(n ¼ 178) was diagnosed according to the Mayo Clinic
criteria and was conﬁrmed via CMR (3,4). Complete
recovery of left ventricular (LV) function within
6 months was documented in all surviving patients.
Continuous electrocardiographic monitoring for at
least 24 h and serial 12-lead electrocardiogram
recording was performed. QT prolongation was de-
ﬁned as QTc >450 ms for male and >460 ms for fe-
male patients. The occurrence of life-threatening
arrhythmias consisting of VT, VF, asystole, and
complete AV block was determined during the hos-
pital stay. VTs lasting >30 s were classiﬁed as sus-
tained. Mortality 1 year after initial presentation was
obtained by telephone contact with the patient or the
treating physician and compared between patients
experiencing arrhythmias and those without ar-
rhythmias. Follow-up after 1 year was available in
169 patients (95%). The 9 patients lost to follow-up
were excluded from survival comparison (Table 1).
The study population consisted of predo-
minantly female patients (87.6%) with a mean age of71.8  10.4 years. A stressful trigger could be identi-
ﬁed in 67.4% of patients, and the majority exhibited
the typical apical ballooning pattern (70.8%). Initial
LV ejection fraction was 44.2  9.3% and recovered to
normal values within 6 months in all patients (60.3 
7.0%). CMR (available in 125 patients) demonstrated
focal edema in 89.2%. Only a few patients (9.2%)
showed subtle ﬁbrosis/necrosis by means of late
gadolinium enhancement when using a threshold of 3
SDs above remote myocardium. QTc prolongation was
identiﬁed in 49.1%.
Life-threatening arrhythmias occurred in 24 pa-
tients (13.5%) (Table 1). Patients developing arrhyth-
mias had a higher prevalence of subtle ﬁbrosis/
necrosis on CMR (33.3% vs. 7.2%; p ¼ 0.04), a lower LV
ejection fraction (39.7  11.0% vs. 44.7  8.4%;
p ¼ 0.02), and they showed a signiﬁcantly longer QTc
(476.5  74.4 ms vs. 442.8  40.9 ms; p < 0.01).
Although all polymorphic VT occurred in the presence
of QTc prolongation, all but 1 patient with mono-
morphic VT had a normal QTc duration. None of the
patients received an implantable cardioverter-
deﬁbrillator, but 3 of the 4 patients with complete AV
block underwent permanent pacemaker implantation.
Mortality 1 year after the index event was signiﬁ-
cantly higher in patients experiencing life-threatening
arrhythmias (10 [44%]) compared with patients
without arrhythmias (14 [10%]; p < 0.01) (Table 1).
Cardiovascular death occurred in 4 TTC patients with
arrhythmias (17%) and 8 patients without arrhythmic
events (5%; p ¼ 0.04). The difference was driven by an
increased mortality in patients experiencing VF; sus-
tained, monomorphic VT; or AV block.
Our results indicate that the prevalence of
arrhythmias in TTC is higher than expected and,
for the ﬁrst time to our knowledge, clearly links these
arrhythmias to worsened survival (1,2). Importantly,
there was a clear divergence of mortality curves
#2 months after initial presentation, which implies
that arrhythmias are of higher prognostic value in
the convalescent phase of TTC. Therefore, our data
illustrate the signiﬁcance of arrhythmic events as a
determinant of outcome and a useful approach to risk
stratiﬁcation in TTC.
Several explanations for the occurrence of ar-
rhythmias in TTC seem reasonable. The high propor-
tion of patients with QTc prolongation indicates a
TABLE 1 Prevalence and Prognostic Effect of Life-Threatening Arrhythmias in Takotsubo Cardiomyopathy
All Patients
(n ¼ 178)
1-Year Mortality*
Hazard Ratio (95% CI) p ValueVariable þ Variable 
Clinical characteristics
Female 156 (87.6) 17/148 (11) 7/21 (33) 0.29 (0.12–0.71) 0.006
Age >70 yrs 116 (65.2) 18/109 (17) 6/60 (10) 1.65 (0.66–4.16) 0.29
Hypertension 145 (81.5) 21/137 (15) 3/32 (9) 1.62 (0.48–5.44) 0.43
Diabetes mellitus 50 (28.1) 10/45 (22) 14/124 (11) 1.92 (0.85–4.33) 0.12
Life-threatening arrhythmias† 24 (13.5) 10/23 (44) 14/146 (10) 5.07 (2.25–11.47) <0.001
Ventricular ﬁbrillation 4 (2.2) 3/4 (75) 21/165 (13) 17.03 (4.56–63.60) <0.001
Ventricular tachycardia 13 (7.3) 5/12 (42) 19/157 (12) 3.63 (1.31–10.07) 0.013
Sustained VT 6 (3.4) 3/5 (60) 21/164 (13) 6.64 (1.94–22.75) 0.003
Nonsustained VT 7 (3.9) 2/7 (29) 22/162 (14) 1.77 (0.41–7.72) 0.45
Monomorphic 8 (4.5) 4/7 (57) 20/162 (12) 5.22 (1.72–15.89) 0.004
Polymorphic 5 (2.8) 1/5 (20) 23/164 (14) 1.32 (0.18–59.94) 0.79
Asystole 5 (2.8) 2/5 (40) 22/164 (13) 2.01 (0.43–9.41) 0.38
Complete AV block 4 (2.2) 2/4 (50) 22/165 (13) 7.13 (1.57–32.39) 0.011
Values are n (%) or n/N (%), unless otherwise indicated. Values in bold are statistically signiﬁcant. Baseline clinical characteristics and frequency of life-threatening arrhythmias
in TTC as well as 1-year mortality according to the variable listed in the ﬁrst column. The presented hazard ratios for life-threatening arrhythmias are age and sex adjusted.
*1-year mortality compared between patients with the clinical characteristic/experiencing the arrhythmia speciﬁed in the ﬁrst column and patients who did not exhibit this
variable. Outcome data after 1 year were available in 169 patients (95%). †Each patient contributed only once to the prevalence of life-threatening arrhythmias, in case several
types of arrhythmias occurred in the same patient.
AV ¼ atrioventricular; CI ¼ conﬁdence interval; TTC ¼ Takotsubo cardiomyopathy; VT ¼ ventricular tachycardia.
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2149potential role of after-depolarizations in the setting of
differences in refractory periods. Consistently, virtu-
ally all polymorphic VTs were associated with QT
prolongation. However, a considerable number of
patients developed monomorphic VT, mostly in the
setting of a normal QT duration. CMR studies de-
monstrate the absence of scar formation in TTC,
which makes re-entry an unlikely underlying mecha-
nism for ventricular arrhythmias (4). However, we
identiﬁed a higher incidence of subtle, diffuse ﬁbrosis/
micronecrosis in patients with arrhythmias, which
may reﬂect a substrate for malignant arrhythmias
(5). Moreover, almost all patients developed myo-
cardial edema that may result in electrical in-
homogeneity predisposing to arrhythmias. Another
possible mechanism is catecholamine excess and
enhanced sympathetic activity. Secondary increase in
vagal tone might explain the occurrence of bradyar-
rhythmias. However, it cannot be excluded that TTC
occurs secondarily due to heart rhythm disease, rather
than representing the substrate for the arrhythmia
in some cases.
The current published data provides limited in-
formation on the management of arrhythmias in the
setting of TTC. In particular, the need for implantable
cardiac-deﬁbrillators is a matter of debate given the
reversible nature of TTC and the substantial number
of noncardiovascular deaths. Considering the lack
of data with respect to recurrence of arrhythmias,
cardiac deﬁbrillator implantation has to be eva-
luated individually. In conclusion, life-threateningarrhythmias are a common ﬁnding in patients with
TTC and have a major prognostic effect.Thomas Stiermaier, MD
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Body Fat Distribution and
Incident Cardiovascular
Disease in Obese AdultsEmerging evidence suggests that signiﬁcant hetero-
geneity exists in the cardiometabolic risk associated
with excess body fat in obese individuals (1). We
investigated the associations of novel imaging
markers of adiposity, including visceral adipose tis-
sue (VAT) and abdominal subcutaneous adipose tis-
sue (SAT) by magnetic resonance imaging, lower body
subcutaneous adipose tissue (LBAT) by dual-energy
x-ray absorptiometry, and liver fat by magnetic
resonance spectroscopy, with the risk for cardiovas-
cular disease (CVD) events in a multiethnic cohort of
obese adults.
The Dallas Heart Study is a cohort study with
methods previously described (1). Participants with
body mass index (BMI) values <30 kg/m2, prevalent
CVD, and missing imaging data were excluded. The
primary outcome was a composite of a ﬁrst or sub-
sequent CVD event: cardiovascular death; myocardial
infarction, hospitalized unstable angina, or coronary
revascularization; ischemic stroke, transient ischemic
attack, or cerebrovascular revascularization; periph-
eral arterial revascularization; hospitalization for
heart failure; or hospitalization for atrial ﬁbrillation.FIGURE 1 Associations of Imaging-Based Markers of Adipose Tissue
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Cumulative incidence of cardiovascular disease (CVD) by visceral (A) andMultivariate-adjusted marginal Cox proportional
hazards modeling using the Wei-Lin-Weissfeld
method for recurrent events (2) was used to calcu-
late hazard ratios and 95% conﬁdence intervals for
the primary outcome associated with baseline mea-
surements of each adiposity marker.
A total of 972 obese participants (mean age 44
years, 62% women, 54% African-Americans) were
followed for a median of 9.1 years. Eighty-one in-
dividuals had ﬁrst or subsequent CVD events,
resulting in 108 events. The cumulative incidence of
CVD increased in a stepwise fashion across sex- and
race-speciﬁc quartiles of VAT, from 5.3% in quartile 1
to 10.0% in quartile 4 (Figure 1A). In contrast, an
opposite association was observed for LBAT: the CVD
event rate was 10.0% in quartile 1 and 5.4% in quartile
4 (Figure 1B). BMI, abdominal SAT, and liver fat were
not associated with CVD. In multivariate analyses
adjusting for age, sex, race, hypercholesterolemia,
smoking status, and BMI, VAT remained associated
with CVD (hazard ratio per 1 SD: 1.21; 95% conﬁdence
interval: 1.03 to 1.43), whereas LBAT was inversely
associated with CVD (hazard ratio per 1 SD: 0.56; 95%
CI: 0.44 to 0.72). Adjustment for hypertension, bio-
markers of inﬂammation, insulin resistance, and
dyslipidemia, and for adipocytokines, did not atten-
uate these associations. Adjustment for baseline dia-
betes status modestly attenuated the association of
VAT with CVD. Lean mass and physical activity both
were inversely associated with CVD and mildly
attenuated the relation between VAT and CVD. Sub-
stitution of waist circumference for BMI showed
generally consistent results; there was no indepen-
dent association of waist circumference with theDistribution With CVD Events
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